1-617-764-4620

Boston Cancer Policy Institute, Inc

Boston Cancer Policy Institute, IncBoston Cancer Policy Institute, IncBoston Cancer Policy Institute, Inc

Boston Cancer Policy Institute, Inc

Boston Cancer Policy Institute, IncBoston Cancer Policy Institute, IncBoston Cancer Policy Institute, Inc
  • Home
  • Contact Us
  • More
    • Home
    • Contact Us
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Contact Us

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

About us

About usAbout us

Boston Cancer Policy Institute is an independent research institute of new social sciences.

See Research Programs

About Us

Dedicated to scholarly research

  • We pursue organizational, managerial, and governance mechanisms that molecular mutations' sciences alter technologies' internal structure and contribute to research policy outcomes.
  • We focus on questions relevant to studies of science policies, management, and governance of knowledge-intensive organizations.
  • What we aim is to contribute to theories and conceptual frameworks that underlie the features of events.


  • Note:   Boston Cancer Policy Institute does not discriminate on the basis of race, color, national origin, sex, age, or disability in its programs or activities.

Background

Boston Cancer Policy Institute was incorporated in Massachusetts in 2012 with a mission below mentioned. Our research programs have continuously evolved to concentrate on managerial and governance aspects of translational sciences (see Research Programs). Ultimate goals are to liberate humans from biological and physiological burdens through scholarly management social science publications and presentations.  

Our Mission

Our missions are to:

  • - conduct policy-oriented research on mechanisms that will advance paths towards individualizing cancer therapeutics and diagnostics, especially for metastasized and rare cancers, and 
  • -contribute to improving cancer and science policy outcomes.   




People:

Chair of the boards: Joseph A. Richmond

Senior Academic Fellow/President: Ellie Okada, Ph.D.

Advisory Board: Marcia V.  Fournier, Ph.D. (National Institute of Health)


Research Programs

  1. We set the following scholarly social science research programs that focus on managerial economics, governance, and social science aspects of translational sciences:
    1.  Governance and management frameworks of translational science.
    2.  Frameworks to facilitate scientific knowledge production and diffusion for sustainability.
    3.  Research policies and governance modality
     

1. Governance and Management Frameworks of Translational Science 

  • This program seeks to contribute to theoretical frameworks of governance and management of translational sciences that are also transferable to other fields of academic sciences.​
        Among the spectrums of translational science, we focus on governance and management issues that occur in the stages of basic research, discoveries, and the process of translating mechanism basis to applications. Thus the clinical research and medical settings are outside of the scope. 

2. Frameworks to facilitate Scientific Knowledge Production and Diffusion for Sustainability 

  •  There are several factors and conditions that promote scientific knowledge production and diffusion.  Sound academic knowledge production is one of necessary conditions.However, there are systemic issues that may hinder the diffusion of the benefits of science.  This research program will identify organizational factors, external contexts. and institutional issues that promote or hinder scientific knowledge production and diffusion for sustainability.  It seeks mechanisms to resolve problems strategically.   


3.  Research Policies and Governance Modality 

  •  The third program is to contribute to scientific research policy frameworks by understanding pathways in which regulatory and governance strategies affect scientists’ and science organizations’ behaviors. The vision is to include more subgroups in the science beneficiaries regardless of their socio-economic status and other conditions.  



  

 
 

Files coming soon.

Major Peer-reviewed Publications and Presentations

  

Peer-reviewed Publications

  

   


Okada, E. (2021). Management of science-intensive organizations: Catalyzing  urban resilience.  Cham, Switzerland: Palgrave Macmillan/Springer International. 

  • https://www.palgrave.com/gp/book/9783030640415
  • https://link.springer.com/book/10.1007/978-3-030-64042-2
  • https://econpapers.repec.org/bookchap/sprsprbok/978-3-030-64042-2.htm

  1. Chapter 1: Research questions and frameworks
  2. Chapter 2: Urban resilience and opportunity identification of social entrepreneurs
  3. Chapter 3: Emerging technologies and organizations for urban resilience
  4. Chapter 4: Addressing environmental inequity by new sciences
  5. Chapter 5: Emergence and dynamism of new material sciences
  6. Chapter 6: Artificial intelligence to broaden beneficiaries
  7. Chapter 7: Scale-up of social enterprises
  8. Chapter 8: Strategy and governance


Okada, E. (2018/ 2019). Management of knowledge-intensive organizations: Governance models for transformative discovery. New York: Palgrave Macmillan/ Switzerland: Springer. 

  •  https://www.palgrave.com/us/book/9783319973722 

  1.  Chapter 1: Introduction  
  2.  Chapter 2: Translational science and boundary conceptualization  
  3.  Chapter 3: Trusteeship governance and challenges to scientific knowledge-intensive organizations  
  4.  Chapter 4: Institutional barriers and governance  
  5.  Chapter 5: Research policy and knowledge-intensive organization  
  6.  Chapter 6:  New governance models for discoveries of vaccine science 
  7.  ​ Chapter 7:  Science and insights from humanistic disciplines  

 Chapter 8: Conclusion 

 Okada E. (2018). Knowledge corruption and governance in academic knowledge-intensive organizations: The case of molecular mutations research, Journal of Public Affairs, 18(1). 

  • https:onlinelibrary.wiley.com/doi/abs/10.1002/pa.1698


Peer-reviewed Presentations


  1. Okada, E. (2022). The 9th World Open Innovation Conference, Eindhoven, The Netherlands, November 15-16, 2022 (Online only session) 
  2. Okada, E. (2022). Problems that social entrepreneurship indeed resolves. Annual Conference. The Society for the Advancement of Socio-Economics. Knowledge, Innovation, Technology, and Entrepreneurship Network. University of Amsterdam. July 11, 2022.  
  3. Okada, E. (2022). Pathways to integrate marginalized population into the workplaces.” Research Paper Session,  2022 Dismantling Bias Conference, Purdue University, March 23-24, 2022. 
  4. Okada, E. (2021),  Entrepreneurial growth of biomedicals: Allocating resources to neglected areas. Annual Conference of Society for the Advancement of Socio-Economics. Virtual, July 2-5, 2021.
  5. Okada, E. (2019). Transnational and comparative dimensions of stem cell science policy. Global Experts Meeting on Frontiers in  Cell & Stem Cell Research. New York, April 18-20, 2019.   
  6.  Okada, E. (2017). International Conference: Responsible Organization in the Global Context, Georgetown University and Universite de Versailles, Washington, D.C., June 15-16, 2017.  
  7.  Okada, E. (2015). The Third Annual Conference on Governance of Emerging Technologies: Law, Policy   and Ethics, Arizona State University Sandra Day O'Connor College of Law,  May 26-28, 2015.   


  

   

Files coming soon.

Files coming soon.

Reviews

0

Copyright © 2022 Boston Cancer Policy Institute, Inc - All Rights Reserved.

Powered by GoDaddy Website Builder